Bristol-Myers Squibb appoints acting chief financial officer
Bristol-Myers Squibb revealed this week that it has appointed Charles Bancroft as its acting chief financial officer from January 1st 2010.
PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that Bristol-Myers Squibb, a global biopharmaceutical company, has established a strategic partnership with PAREXEL to enable greater effectiveness in clinical development.